Thyroid hormone resistance: the role of mutational analysis

The finding of increased thyroxine (T4) and tri‐iodothyronine (T3) levels in a patient with normal or increased thyroid‐stimulating hormone is unexpected and presents a differential diagnosis between a thyroid‐stimulating hormone‐secreting pituitary adenoma, generalized resistance to thyroid hormone...

Full description

Saved in:
Bibliographic Details
Published in:Internal medicine journal Vol. 36; no. 11; pp. 738 - 741
Main Authors: Florkowski, C. M., Brownlie, B. E. W., Croxson, M. S., Manning, P., Farrand, S., Smith, G., Potter, H. C., George, P. M.
Format: Journal Article
Language:English
Published: Melbourne, Australia Blackwell Publishing Asia 01-11-2006
Blackwell Science
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The finding of increased thyroxine (T4) and tri‐iodothyronine (T3) levels in a patient with normal or increased thyroid‐stimulating hormone is unexpected and presents a differential diagnosis between a thyroid‐stimulating hormone‐secreting pituitary adenoma, generalized resistance to thyroid hormone (RTH) and laboratory artefact. Without careful clinical and biochemical evaluation, errors may occur in patient diagnosis and treatment. In the case of RTH, mutation of the thyroid hormone receptor beta gene results in generalized tissue resistance to thyroid hormone. As the pituitary gland shares in this tissue resistance, euthyroidism with a normal thyroid‐stimulating hormone is usually maintained by increased thyroid hormones. To date, we have identified eight pedigrees in New Zealand with mutations in the thyroid hormone receptor beta gene, including two novel mutations. Mutational analysis of the thyroid hormone receptor beta gene allows definitive diagnosis of RTH, potentially avoiding the need for protracted and expensive pituitary function testing and imaging. Mutational analysis also enables family screening and may help to avoid potential misdiagnosis and inappropriate treatment.
Bibliography:ArticleID:IMJ1189
istex:1872A11C5482765A567CBD1921BCA9694CEEF61B
ark:/67375/WNG-QQG9Z3H5-B
Funding: None
Potential conflicts of interest: None
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1444-0903
1445-5994
DOI:10.1111/j.1445-5994.2006.01189.x